We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$338M
AUM Growth
-$63.5K
Cap. Flow
+$25.1M
Cap. Flow %
7.43%
Top 10 Hldgs %
93.46%
Holding
23
New
2
Increased
3
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$25.1M
2
KVYO icon
Klaviyo
KVYO
+$16.1M
3
CRWD icon
CrowdStrike
CRWD
+$18.8K
4
TOST icon
Toast
TOST
+$18.1K
5
SNOW icon
Snowflake
SNOW
+$14.8K

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$16.1M
2
CFLT
Confluent
CFLT
+$6.47K

Sector Composition

Rank Sector Weight
1 Technology 37.18%
2 Healthcare 28.96%
3 Financials 19.63%
4 Consumer Discretionary 14.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NU icon
1
Nu Holdings
NU
$73.6B
$66.4M 19.63%
9,152,548
– –
PATH icon
2
UiPath
PATH
$8.3B
$52.5M 15.52%
3,066,569
– –
DASH icon
3
DoorDash
DASH
$94B
$48M 14.19%
603,512
– –
SNOW icon
4
Snowflake
SNOW
$114B
$33M 9.75%
215,799
+91
+0% +$14.8K
RYZB
5
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$26.5M 7.85%
+1,195,589
New +$25.1M
IOT icon
6
Samsara
IOT
$23.2B
$23.6M 6.97%
934,737
-608,710
-39% -$16.1M
TXG icon
7
10x Genomics
TXG
$7.31B
$19.9M 5.88%
481,770
– –
KVYO icon
8
Klaviyo
KVYO
$5.26B
$16.2M 4.79%
+469,431
New +$16.1M
ACRV icon
9
Acrivon Therapeutics
ACRV
$83.6M
$15.8M 4.67%
1,652,605
– –
ABOS icon
10
Acumen Pharmaceuticals
ABOS
$193M
$14.2M 4.2%
3,417,075
– –
OLK
11
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$10.4M 3.08%
705,514
– –
TARS icon
12
Tarsus Pharmaceuticals
TARS
$3.04B
$4.62M 1.37%
260,000
– –
TSHA icon
13
Taysha Gene Therapies
TSHA
$1.94B
$2.29M 0.68%
724,873
– –
SPRB
14
Spruce Biosciences
SPRB
$151M
$1.78M 0.53%
10,493
– –
MASS icon
15
908 Devices
MASS
$414M
$1.58M 0.47%
237,258
– –
CADL icon
16
Candel Therapeutics
CADL
$897M
$747K 0.22%
811,737
– –
CRWD icon
17
CrowdStrike
CRWD
$221B
$145K 0.04%
3,460
+484
+16% +$18.8K
CPNG icon
18
Coupang
CPNG
$29B
$143K 0.04%
8,438
– –
TOST icon
19
Toast
TOST
$20.1B
$133K 0.04%
7,121
+834
+13% +$18.1K
DDOG icon
20
Datadog
DDOG
$91.7B
$124K 0.04%
1,366
– –
ABSI icon
21
Absci
ABSI
$1.58B
$76.3K 0.02%
57,804
– –
CFLT
22
DELISTED
Confluent
CFLT
$34.4K 0.01%
1,161
-193
-14% -$6.47K
GTLB icon
23
GitLab
GTLB
$7.2B
$29.8K 0.01%
658
– –

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q3 2023 Portfolio in Review

As of Q3 2023, Sands Capital Ventures held 23 positions worth $338M, down 0.02% from $338M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Sands Capital Ventures deployed $25.1M of net new capital in Q3 2023, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was RayzeBio, Inc. Common Stock: 1,195,589 shares worth $26.5M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Samsara, an estimated $16.1M trimmed.

  • Sands Capital Ventures's largest Q3 2023 buy was RayzeBio, Inc. Common Stock: 1,195,589 shares worth $26.5M.
  • Sands Capital Ventures added most to CrowdStrike in Q3 2023, an estimated $18.8K increase.
  • Sands Capital Ventures's biggest Q3 2023 reduction was Samsara, cutting an estimated $16.1M.
  • Sands Capital Ventures's ten largest holdings make up 93% of its $338M portfolio in Q3 2023.
  • Sands Capital Ventures opened 2 new positions and closed 0 in Q3 2023.
  • Sands Capital Ventures's portfolio value fell 0.02% quarter-over-quarter to $338M.

Based on Sands Capital Ventures's 13F filing for Q3 2023, filed 14 Nov 2023.